Evidence map›Paper›PMID 33934536›Full record

Trial reportESC heart failure2021

Predictors and prognosis of right ventricular function in pulmonary hypertension due to heart failure with reduced ejection fraction.

Alexander Schmeißer, Thomas Rauwolf, Thomas Groscheck, Katharina Fischbach, Siegfried Kropf, Blerim Luani, Ivan Tanev, Michael Hansen, Saskia Meißler, Kerstin Schäfer and 2 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in ESC heart failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Right ventricular function in pulmonary hypertension and obesity: a cross-sectional cohort study with survival follow-up.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Alexander SchmeißerDepartment of Internal Medicine, Division of Cardiology and Angiology, Magdeburg University, Leipziger Str. 44, Magdeburg, D-39120, Germany.
Thomas RauwolfDepartment of Internal Medicine, Division of Cardiology and Angiology, Magdeburg University, Leipziger Str. 44, Magdeburg, D-39120, Germany.ORCID 0000-0001-5542-8539
Thomas GroscheckDepartment of Internal Medicine, Division of Cardiology and Angiology, Magdeburg University, Leipziger Str. 44, Magdeburg, D-39120, Germany.
Katharina FischbachDepartment of Radiology, Magdeburg University, Magdeburg, Germany.
Siegfried KropfInstitute of Biometry and Medical Informatics, Magdeburg University, Magdeburg, Germany.
Blerim LuaniDepartment of Internal Medicine, Division of Cardiology and Angiology, Magdeburg University, Leipziger Str. 44, Magdeburg, D-39120, Germany.
Ivan TanevDepartment of Internal Medicine, Division of Cardiology and Angiology, Magdeburg University, Leipziger Str. 44, Magdeburg, D-39120, Germany.
Michael HansenDepartment of Internal Medicine, Division of Cardiology and Angiology, Magdeburg University, Leipziger Str. 44, Magdeburg, D-39120, Germany.
Saskia MeißlerDepartment of Internal Medicine, Division of Cardiology and Angiology, Magdeburg University, Leipziger Str. 44, Magdeburg, D-39120, Germany.
Kerstin SchäferDepartment of Internal Medicine, Division of Cardiology and Angiology, Magdeburg University, Leipziger Str. 44, Magdeburg, D-39120, Germany.
Paul SteendijkDepartment of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
Ruediger C Braun-DullaeusDepartment of Internal Medicine, Division of Cardiology and Angiology, Magdeburg University, Leipziger Str. 44, Magdeburg, D-39120, Germany.
University Hospital Magdeburg · DELeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsFailure of right ventricular (RV) function worsens outcome in pulmonary hypertension (PH). The adaptation of RV contractility to afterload, the RV-pulmonary artery (PA) coupling, is defined by the ratio of RV end-systolic to PA elastances (Ees/Ea). Using pressure-volume loop (PV-L) technique we aimed to identify an Ees/Ea cut-off predictive for overall survival and to assess hemodynamic and morphologic conditions for adapted RV function in secondary PH due to heart failure with reduced ejection fraction (HFREF). METHODS AND

resultsThis post hoc analysis is based on 112 patients of the prospective Magdeburger Resynchronization Responder Trial. All patients underwent right and left heart echocardiography and a baseline PV-L and RV catheter measurement. A subgroup of patients (n = 50) without a pre-implanted cardiac device underwent magnetic resonance imaging at baseline. The analysis revealed that 0.68 is an optimal Ees/Ea cut-off (area under the curve: 0.697, P < 0.001) predictive for overall survival (median follow up = 4.7 years, Ees/Ea ≥ 0.68 vs. <0.68, log-rank 8.9, P = 0.003). In patients with PH (n = 76, 68%) multivariate Cox regression demonstrated the independent prognostic value of RV-Ees/Ea in PH patients (hazard ratio 0.2, P < 0.038). Patients without PH (n = 36, 32%) and those with PH but RV-Ees/Ea ≥ 0.68 showed comparable RV-Ees/Ea ratios (0.88 vs. 0.9, P = 0.39), RV size/function, and survival. In contrast, secondary PH with RV-PA coupling ratio Ees/Ea < 0.68 corresponded extremely close to cut-off values that define RV dilatation/remodelling (RV end-diastolic volume >160 mL, RV-mass/volume-ratio ≤0.37 g/mL) and dysfunction (right ventricular ejection fraction <38%, tricuspid annular plane systolic excursion <16 mm, fractional area change <42%, and stroke-volume/end-systolic volume ratio <0.59) and is associated with a dramatically increased short and medium-term all-cause mortality. Independent predictors of prognostically unfavourable RV-PA coupling (Ees/Ea < 0.68) in secondary PH were a pre-existent dilated RV [end-diastolic volume >171 mL, odds ratio (OR) 0.96, P = 0.021], high pulsatile load (PA compliance <2.3 mL/mmHg, OR 8.6, P = 0.003), and advanced systolic left heart failure (left ventricular ejection fraction <30%, OR 1.23, P = 0.028).

conclusionsThe RV-PA coupling ratio Ees/Ea predicts overall survival in PH due to HFREF and is mainly affected by pulsatile load, RV remodelling, and left ventricular dysfunction. Prognostically favourable coupling (RV-Ees/Ea ≥ 0.68) in PH was associated with preserved RV size/function and mid-term survival, comparable with HFREF without PH.

Indexed as

Heart FailureHypertension, PulmonaryVentricular Dysfunction, RightHumansPrognosisProspective StudiesStroke VolumeVentricular Function, LeftVentricular Function, RightArterial elastanceEnd-systolic elastancePressure-volume loopsRight ventricle-pulmonary arterial couplingRVEF, TAPSE, FAC, PA compliance

Identifiers

PMID33934536
PMCPMC8318446
OpenAlexW3159090118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.